0001062993-18-002689.txt : 20180620 0001062993-18-002689.hdr.sgml : 20180620 20180620202007 ACCESSION NUMBER: 0001062993-18-002689 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180620 FILED AS OF DATE: 20180620 DATE AS OF CHANGE: 20180620 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wegman Mark N CENTRAL INDEX KEY: 0001405235 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34236 FILM NUMBER: 18910683 MAIL ADDRESS: STREET 1: 43 OVERLOOK ROAD CITY: OSSINING STATE: NY ZIP: 10562 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSPECIFICS TECHNOLOGIES CORP CENTRAL INDEX KEY: 0000875622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 113054851 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 WILBUR ST CITY: LYNBROOK STATE: NY ZIP: 11563 BUSINESS PHONE: 5165937000 MAIL ADDRESS: STREET 1: 35 WILBUR STREET CITY: LYNBROOK STATE: NY ZIP: 11563 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2018-06-20 0000875622 BIOSPECIFICS TECHNOLOGIES CORP BSTC 0001405235 Wegman Mark N C/O BIOSPECIFICS TECHNOLOGIES CORP. 35 WILBUR STREET LYNBROOK NY 11563 1 0 0 0 Common Stock, $0.001 par value 2018-06-20 4 C 0 15000 17.00 A 80272 D Stock Option (Right to Buy) 17.00 2018-06-20 4 C 0 15000 0 D 2018-06-25 Cmn Stk $.001pv 15000 0 D The option vests monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. /s/ Mark Wegman by Carl A. Valenstein, attorney- in-fact 2018-06-20